非复杂性B型主动脉夹层背后的复杂遗传学
本文综述了与胸主动脉瘤和夹层相关的基因变异对B型主动脉夹层临床结局的影响。病例研究显示,携带原纤维蛋白-1、III型胶原、α-肌动蛋白2、MYH11、cGMP依赖性蛋白激酶I型、转化生长因子β1及其I型和II型受体基因变异的患者疾病进展更快并从手术中获益。结论认为基因变异可影响非复杂性B型主动脉夹层的临床决策与风险分层,新兴证据支持对并发症高风险患者行胸主动脉腔内修复。
要点
- 携带原纤维蛋白-1、III型胶原、α-肌动蛋白2、MYH11、cGMP依赖性蛋白激酶I型、转化生长因子β1及其I型和II型受体基因变异的B型主动脉夹层患者疾病进展更快。
- 上述基因变异患者可从手术中获益。
- 基因检测可能有助于非复杂性B型主动脉夹层的风险分层与临床决策。
核心结论
- 非复杂性B型主动脉夹层病因相关基因的变异可影响其临床决策与风险分层。
- 新兴证据支持对并发症高风险的非复杂性B型主动脉夹层患者行胸主动脉腔内修复。
- 在非复杂性B型主动脉夹层管理中应用遗传学可能有助于改善不良临床结局。
研究设计与样本
- 使用多个电子数据库进行的综合性文献综述。
- 选取在胸主动脉瘤和夹层中已知的基因,研究其与B型主动脉夹层临床结局的关联。
主要发现
- 病例研究显示原纤维蛋白-1、III型胶原、α-肌动蛋白2、MYH11、cGMP依赖性蛋白激酶I型、转化生长因子β1、I型转化生长因子β受体和II型转化生长因子β受体基因变异影响B型主动脉夹层的临床结局。
- 携带这些基因变异的患者疾病进展更迅速,并从手术中获益。
- 高达50%的非复杂性B型主动脉夹层病例会进展为复杂性,发病后5年内死亡率高达42%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Up to 50% of uncomplicated type B aortic dissection (unTBAD) cases progress to become complicated with a mortality rate of up to 42% within 5 years of onset. Morphological and clinical parameters have previously been defined for the decision of surgical intervention in unTBAD to improve clinical outcomes. The analysis of genetic variants in this risk stratification has demonstrated a lack of evidence to influence clinical decision-making. METHODS: A comprehensive literature review was conducted using multiple electronic databases. A selection of genes recognized in thoracic aortic aneurysms and dissections were investigated in association with clinical outcomes in type B aortic dissections. RESULTS: Case studies highlighted the impact of variants in fibrillin-1, type III collagen, alpha-actin 2, MYH11, protein kinase cGMP-dependent type I, transforming growth factor beta 1, type I transforming growth factor β receptor, and type II transforming growth factor β receptor on clinical outcomes in type B aortic dissection. Patients who carry variants in these genes experience more rapid disease progression and benefit from surgery. CONCLUSION: The presence of a variant in genes that underlie unTBAD etiology could impact clinical decision-making and risk stratification in unTBAD. Emerging evidence supports thoracic endovascular aortic repair for unTBAD patients who have a higher risk of developing complications. The use of genetics in the management of unTBAD patients may help to improve the adverse clinical outcomes in unTBAD.
引用
- Auton E, Kamal M, Jubouri M, et al. The Complicated Genetics behind Uncomplicated Type B Aortic Dissection. Ann Vasc Surg. 2025. PMID: 40058456. doi:10.1016/j.avsg.2025.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。